These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32921792)

  • 1. Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.
    Nonaka M; Suzuki-Anekoji M; Nakayama J; Mabashi-Asazuma H; Jarvis DL; Yeh JC; Yamasaki K; Akama TO; Huang CT; Campos AR; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Shibata TK; Sugihara K; Nishizawa-Harada C; Fukuda M; Fukuda MN
    Br J Cancer; 2020 Nov; 123(11):1633-1643. PubMed ID: 32921792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor vasculature-targeted
    Yoneyama T; Hatakeyama S; Sutoh Yoneyama M; Yoshiya T; Uemura T; Ishizu T; Suzuki M; Hachinohe S; Ishiyama S; Nonaka M; Fukuda MN; Ohyama C
    BMC Cancer; 2021 Jan; 21(1):72. PubMed ID: 33446132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
    Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
    PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two phosphorylation sites essential for annexin A1 in blood-brain barrier protection after experimental intracerebral hemorrhage in rats.
    Wang Z; Chen Z; Yang J; Yang Z; Yin J; Zuo G; Duan X; Shen H; Li H; Chen G
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2509-2525. PubMed ID: 27634935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.
    Pan Y; Zhong LJ; Zhou H; Wang X; Chen K; Yang HP; Xiaokaiti Y; Maimaiti A; Jiang L; Li XJ
    Acta Pharmacol Sin; 2012 Jun; 33(6):798-808. PubMed ID: 22669117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
    Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A1 restores Aβ
    Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
    Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor targeting by a carbohydrate ligand-mimicking peptide.
    Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
    Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR7 regulates B16 murine melanoma cell tumorigenesis in skin.
    Fang L; Lee VC; Cha E; Zhang H; Hwang ST
    J Leukoc Biol; 2008 Oct; 84(4):965-72. PubMed ID: 18519742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination.
    Rondepierre F; Bouchon B; Papon J; Bonnet-Duquennoy M; Kintossou R; Moins N; Maublant J; Madelmont JC; D'Incan M; Degoul F
    Biochim Biophys Acta; 2009 Jan; 1794(1):61-9. PubMed ID: 18952200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumours can act as adjuvants for humoral immunity.
    Brown DM; Fisher TL; Wei C; Frelinger JG; Lord EM
    Immunology; 2001 Apr; 102(4):486-97. PubMed ID: 11328383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
    Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
    J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.
    Yung R; Seyfoddin V; Guise C; Tijono S; McGregor A; Connor B; Ching LM
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):639-49. PubMed ID: 24477604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy.
    Huang Y; Wang L; Cheng Z; Yang B; Yu J; Chen Y; Lu W
    J Control Release; 2021 Nov; 339():297-306. PubMed ID: 34619226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.
    García-Hernández ML; Hernández-Pando R; Gariglio P; Berumen J
    Immunology; 2002 Feb; 105(2):231-43. PubMed ID: 11872099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells.
    Li L; Zou J; Dai Y; Fan W; Niu G; Yang Z; Chen X
    Nat Biomed Eng; 2020 Nov; 4(11):1102-1116. PubMed ID: 32807941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines.
    Miwa T; Kanda M; Umeda S; Tanaka H; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
    In Vivo; 2019; 33(6):1785-1792. PubMed ID: 31662503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.